Pipeline 2 Header


The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules.

Conferences Include:

1月8日 - 9日

Engineering Next-Generation Cancer Immunotherapies ( 次世代がん免疫療法の開発 )

1月9日 - 10日

Antibody-Drug Conjugates ( 抗体薬物複合体 )

1月11日 - 12日

Bispecific Antibody Therapeutics ( 二重特異性抗体療法 )